Male Sexual Dysfunction (Erectile Dysfunction) Protocol
Primary Stack
Core supplements with strongest evidenceIncreases arginine and nitric oxide production, improving blood flow to erectile tissue
Supporting Studies (1)
Ginsenosides enhance nitric oxide release, improve smooth muscle relaxation, and support testosterone
Supporting Stack
Additional supplements for enhanced resultsAdaptogen that improves sexual desire and may enhance erectile function independent of hormones
Supporting Studies (1)
Pine bark extract that enhances endothelial nitric oxide production and blood flow
Supporting Studies (1)
May increase testosterone and reduce cortisol, improving libido and erectile function
Supporting Studies (1)
Contains furostanolic saponins that may support testosterone and enhance libido
Supporting Studies (1)
Essential for testosterone production; deficiency impairs sexual function
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Erectile dysfunction (ED) affects up to 50% of men over 40 to some degree. While it can have psychological components, ED is often a vascular issue—erections depend on adequate blood flow. In fact, ED can be an early warning sign of cardiovascular disease. This protocol supports erectile function through improving blood flow and supporting healthy testosterone levels.
IMPORTANT: ED can signal underlying cardiovascular disease, diabetes, or hormonal issues. Get evaluated by a healthcare provider before relying solely on supplements.
Expected timeline: Citrulline and Pycnogenol may show effects within days to weeks. Ginseng: 2-4 weeks. Maca and Tongkat Ali: 4-8 weeks for full effects. Address cardiovascular health for long-term improvement.
Clinical Perspective
Erectile dysfunction involves failure to achieve or maintain an erection sufficient for satisfactory sexual performance. Pathophysiology is primarily vascular (80%) involving endothelial dysfunction and impaired NO-cGMP signaling. Risk factors include cardiovascular disease, diabetes, hypertension, obesity, smoking, and medications (antihypertensives, SSRIs). ED is an independent predictor of cardiovascular events. This protocol targets NO-mediated vasodilation and hormonal optimization.
Biomarker targets: IIEF-5 score (validated ED assessment), testosterone (total, free), SHBG, prolactin, glucose/HbA1c, lipid panel, PSA (if indicated), cardiovascular risk assessment.
Protocol notes: PDE5 inhibitors (sildenafil, tadalafil) remain first-line for ED and are highly effective. Supplements may be adjunctive or for mild cases. Address underlying conditions: optimize cardiovascular health, control diabetes, stop smoking, exercise regularly, lose excess weight. Psychological factors: consider sex therapy if anxiety/performance issues. Low testosterone: may require TRT (medical decision). Avoid unregulated 'male enhancement' products (often contain hidden PDE5 inhibitors). Vacuum devices and penile injections are options for refractory cases. Tadalafil daily (2.5-5mg) also treats BPH.